Design Therapeutics, Inc.
DSGN
$14.83
$0.443.06%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.34% | -10.25% | 5.88% | 10.93% | -7.72% |
| Total Depreciation and Amortization | -3.82% | 0.64% | 0.65% | 1.97% | -4.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.08% | 31.94% | 3.52% | -19.45% | 41.25% |
| Change in Net Operating Assets | 120.16% | -391.46% | -66.48% | 188.13% | 158.20% |
| Cash from Operations | 5.52% | -37.31% | -7.20% | 22.71% | 13.99% |
| Capital Expenditure | -- | -- | -- | 100.00% | -20.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 298.67% | 34.29% | -277.40% | -67.78% | 154.38% |
| Cash from Investing | 298.39% | 34.48% | -277.93% | -67.64% | 155.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.96% | -21.26% | 68,324.32% | -89.75% | 1,469.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -96.96% | -21.26% | 68,324.32% | -89.75% | 1,469.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 103.35% | -331.11% | 138.31% | -176.46% | 167.85% |